Cue Biopharma, Inc. (CUE)
28.74
+0.74
(+2.64%)
USD |
NASDAQ |
Sep 11, 16:00
28.83
+0.09
(+0.31%)
Pre-Market: 20:00
Cue Biopharma Profit Margin (Quarterly) : -1.94K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.94K% |
| March 31, 2026 | -91.07% |
| December 31, 2025 | 7.22% |
| September 30, 2025 | -346.6% |
| June 30, 2025 | -287.1% |
| March 31, 2025 | -2.91K% |
| December 31, 2024 | -602.5% |
| September 30, 2024 | -259.6% |
| June 30, 2024 | -382.7% |
| March 31, 2024 | -719.1% |
| December 31, 2023 | -737.7% |
| September 30, 2023 | -524.0% |
| June 30, 2023 | -954.1% |
| March 31, 2023 | -7.01K% |
| December 31, 2022 | -9.65K% |
| September 30, 2022 | -16.11K% |
| June 30, 2022 | -50.80K% |
| Date | Value |
|---|---|
| March 31, 2022 | -1.43K% |
| December 31, 2021 | -101.6% |
| September 30, 2021 | -542.5% |
| June 30, 2021 | -375.3% |
| March 31, 2021 | -805.2% |
| December 31, 2020 | -2.34K% |
| September 30, 2020 | -1.42K% |
| June 30, 2020 | -1.01K% |
| March 31, 2020 | -1.42K% |
| December 31, 2019 | -849.8% |
| September 30, 2019 | -710.4% |
| June 30, 2019 | -902.6% |
| March 31, 2019 | -3.05K% |
| December 31, 2018 | -3.52K% |
| September 30, 2018 | -2.80K% |
| June 30, 2018 | -4.24K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Nurix Therapeutics, Inc. | -990.1% |
| Monte Rosa Therapeutics, Inc. | -483.9% |
| Xilio Therapeutics, Inc. | -34.09% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.00K% |
| Return on Assets | -463.4% |
| Return on Invested Capital | -732.6% |
| Gross Profit Margin (Quarterly) | 99.54% |
| Operating Margin (Quarterly) | -1.11K% |
| Return on Net Operating Assets | -2.11K% |